Professor Elliott with Dr Danielle Anderson Musculoskeletal Medicine and Rehabilitation Lead–Space Medicine Operations, NASA
Revolutionary approach to mapping muscle health The MuscleMap tool will support the diagnosis and treatment of musculoskeletal and neurological conditions, including osteoporosis, cancer, Parkinson’s disease, sarcopenia and frailty. An estimated 4 billion people “Currently, we can identify these changes by manually assessing CT and MRI scans, but the process takes many hours, making it unfeasible,” he said.
The long-term vision is for MuscleMap to operate as a true push-button system–where a clinician will perform a scan, and within minutes receive a comprehensive set of muscle- health metrics that can easily be interpreted in a clinical context. MuscleMap will be applied to rehabilitation, disease assessment and management, elite sports health and optimal performance.
“MuscleMap however, will use available MRI and CT scans and artificial intelligence, to detect changes in muscle health rapidly and accurately. “From athletes to astronauts and the general population, MuscleMap will accurately inform the journey from injury to repair, recovery and return to physical activity, informing personalised strategies to develop healthier muscle mass and improve general health and wellbeing.”
worldwide are impacted by these conditions, with healthcare costs in Australia alone set to triple to $21 billion by 2033. MuscleMap will help detect disease earlier, enabling timely treatment and significantly better health outcomes. Professor Elliott said we know these conditions often lead to a rapid and steady decline in muscle health, and this decline is evident by an increase in fat deposits in the muscles and the loss of muscle fibres.
7
WWW.KOLLINGINSTITUTE.ORG.AU
Made with FlippingBook - professional solution for displaying marketing and sales documents online